Israeli researchers discover MS drug could help epilepsy patients

Tel Aviv University researchers have discovered that a drug used in the treatment of multiple sclerosis may be adapted to help epilepsy patients.

The development is significant because 30-40 percent of epilepsy patients do not respond to the pharmaceutical treatments available today, particularly children with a rare and severe form of the disorder called Dravet Syndrome, a university statement said on Monday.

I’ve said for some time that if we can cure multiple sclerosis we will learn enough to be able to cure other diseases such as epilepsy, Parkinson’s, etc.

In this case it appears a step forward was made with epilepsy by using an MS medication called Aubagio approved by the FDA on September 2012.

Leave a Reply

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s